HUP0105430A3 - Attenuated bacteria and vaccines containing thereof - Google Patents
Attenuated bacteria and vaccines containing thereofInfo
- Publication number
- HUP0105430A3 HUP0105430A3 HU0105430A HUP0105430A HUP0105430A3 HU P0105430 A3 HUP0105430 A3 HU P0105430A3 HU 0105430 A HU0105430 A HU 0105430A HU P0105430 A HUP0105430 A HU P0105430A HU P0105430 A3 HUP0105430 A3 HU P0105430A3
- Authority
- HU
- Hungary
- Prior art keywords
- vaccines containing
- attenuated bacteria
- attenuated
- bacteria
- vaccines
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title 1
- 230000002238 attenuated effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/02—Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion
- C12N15/03—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- Mycology (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9806449.6A GB9806449D0 (en) | 1998-03-25 | 1998-03-25 | Attenuated bacteria useful in vaccines |
PCT/GB1999/000935 WO1999049026A1 (en) | 1998-03-25 | 1999-03-25 | Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines |
Publications (3)
Publication Number | Publication Date |
---|---|
HUP0105430A2 HUP0105430A2 (hu) | 2002-04-29 |
HUP0105430A3 true HUP0105430A3 (en) | 2004-10-28 |
HU225644B1 HU225644B1 (en) | 2007-05-02 |
Family
ID=10829280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0105430A HU225644B1 (en) | 1998-03-25 | 1999-03-25 | Attenuated bacteria and vaccines containing thereof |
Country Status (19)
Country | Link |
---|---|
US (1) | US6902906B1 (hu) |
EP (1) | EP1066376B1 (hu) |
JP (1) | JP4516210B2 (hu) |
KR (1) | KR100628657B1 (hu) |
AT (1) | ATE296881T1 (hu) |
AU (1) | AU763683B2 (hu) |
CA (1) | CA2323576C (hu) |
CZ (1) | CZ301520B6 (hu) |
DE (1) | DE69925585T2 (hu) |
DK (1) | DK1066376T3 (hu) |
ES (1) | ES2244182T3 (hu) |
GB (1) | GB9806449D0 (hu) |
HU (1) | HU225644B1 (hu) |
NO (1) | NO327609B1 (hu) |
NZ (1) | NZ507077A (hu) |
PL (1) | PL196076B1 (hu) |
PT (1) | PT1066376E (hu) |
WO (1) | WO1999049026A1 (hu) |
ZA (1) | ZA200004987B (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138237B1 (en) * | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
DK1352245T3 (da) * | 2001-01-18 | 2006-12-18 | Univ Newcastle Ventures Ltd | Biosensor med kovalent bundne membranspændende proteiner |
GB0121998D0 (en) | 2001-09-11 | 2001-10-31 | Acambis Res Ltd | Attenuated bacteria useful in vaccines |
US7357935B2 (en) * | 2003-05-14 | 2008-04-15 | Wyeth | Avian E. coli vaccine for protection against colibacillosis |
US7297338B2 (en) * | 2003-05-14 | 2007-11-20 | Wyeth | Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella |
WO2007089205A1 (en) * | 2006-02-01 | 2007-08-09 | Sbl Vaccin Ab | Colonization factor (cf) antigens of enterotoxigenic escherichia coli in recombinant bacteria |
JP2008054614A (ja) * | 2006-09-01 | 2008-03-13 | Nippon Inst For Biological Science | 鶏大腸菌由来弱毒変異株、鶏大腸菌対策用ワクチン、免疫方法及び鶏用ワクチンベクター |
EP2517723B1 (en) | 2006-09-18 | 2019-11-06 | The Board of Trustees of The University of Arkansas | Compositions and methods of enhancing immune responses |
JP2011502165A (ja) * | 2007-10-30 | 2011-01-20 | ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ アーカンソー | 鞭毛細菌に対する免疫応答を強化する組成物および方法 |
NZ585777A (en) | 2007-11-01 | 2012-09-28 | Univ Arkansas | Compositions and methods of enhancing immune responses to eimeria |
EA023058B1 (ru) | 2010-01-21 | 2016-04-29 | Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Арканзас | Вакцинные векторы и способы усиления иммунных ответов |
KR102007132B1 (ko) | 2010-06-09 | 2019-08-05 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 캄필로박터 감염을 감소시키기 위한 백신 및 방법 |
WO2014037445A1 (en) * | 2012-09-05 | 2014-03-13 | Lohmann Animal Health Gmbh | Preparation of live vaccines |
NZ709154A (en) | 2012-12-07 | 2019-10-25 | Elanco Tiergesundheit Ag | Preparation of live vaccines |
EP3610887B8 (en) | 2013-02-14 | 2024-01-24 | The Board of Trustees of the University of Arkansas | Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection |
BR112015023024B1 (pt) | 2013-03-15 | 2022-04-19 | The Board Of Trustees Of The University Of Arkansas | Vetor de vacina e composições farmacêuticas compreendendo o mesmo |
SG11201809686SA (en) | 2016-05-03 | 2018-11-29 | Univ Arkansas | Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8730037D0 (en) | 1987-12-23 | 1988-02-03 | Wellcome Found | Vaccines |
GB8912330D0 (en) | 1989-05-30 | 1989-07-12 | Wellcome Found | Live vaccines |
EP0441071B1 (en) | 1990-02-06 | 1994-09-21 | Institut Pasteur | Transformed shigella |
GB9007194D0 (en) | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
ES2131069T3 (es) * | 1991-03-05 | 1999-07-16 | Wellcome Found | Expresion de proteinas recombinantes en bacterias atenuadas. |
-
1998
- 1998-03-25 GB GBGB9806449.6A patent/GB9806449D0/en not_active Ceased
-
1999
- 1999-03-25 EP EP99911949A patent/EP1066376B1/en not_active Expired - Lifetime
- 1999-03-25 DE DE69925585T patent/DE69925585T2/de not_active Expired - Lifetime
- 1999-03-25 DK DK99911949T patent/DK1066376T3/da active
- 1999-03-25 HU HU0105430A patent/HU225644B1/hu not_active IP Right Cessation
- 1999-03-25 CZ CZ20003470A patent/CZ301520B6/cs not_active IP Right Cessation
- 1999-03-25 KR KR1020007010633A patent/KR100628657B1/ko not_active IP Right Cessation
- 1999-03-25 CA CA2323576A patent/CA2323576C/en not_active Expired - Fee Related
- 1999-03-25 PL PL343246A patent/PL196076B1/pl not_active IP Right Cessation
- 1999-03-25 AT AT99911949T patent/ATE296881T1/de active
- 1999-03-25 AU AU30458/99A patent/AU763683B2/en not_active Ceased
- 1999-03-25 JP JP2000537987A patent/JP4516210B2/ja not_active Expired - Fee Related
- 1999-03-25 PT PT99911949T patent/PT1066376E/pt unknown
- 1999-03-25 US US09/646,925 patent/US6902906B1/en not_active Expired - Fee Related
- 1999-03-25 NZ NZ507077A patent/NZ507077A/xx unknown
- 1999-03-25 WO PCT/GB1999/000935 patent/WO1999049026A1/en active IP Right Grant
- 1999-03-25 ES ES99911949T patent/ES2244182T3/es not_active Expired - Lifetime
-
2000
- 2000-09-19 ZA ZA200004987A patent/ZA200004987B/en unknown
- 2000-09-25 NO NO20004781A patent/NO327609B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PT1066376E (pt) | 2005-10-31 |
EP1066376A1 (en) | 2001-01-10 |
ATE296881T1 (de) | 2005-06-15 |
NO327609B1 (no) | 2009-08-31 |
CA2323576A1 (en) | 1999-09-30 |
HUP0105430A2 (hu) | 2002-04-29 |
KR20010042175A (ko) | 2001-05-25 |
JP2002507414A (ja) | 2002-03-12 |
GB9806449D0 (en) | 1998-05-27 |
AU763683B2 (en) | 2003-07-31 |
ES2244182T3 (es) | 2005-12-01 |
DE69925585T2 (de) | 2006-07-13 |
ZA200004987B (en) | 2001-10-31 |
JP4516210B2 (ja) | 2010-08-04 |
AU3045899A (en) | 1999-10-18 |
DK1066376T3 (da) | 2005-10-03 |
PL196076B1 (pl) | 2007-12-31 |
EP1066376B1 (en) | 2005-06-01 |
HU225644B1 (en) | 2007-05-02 |
CZ20003470A3 (cs) | 2001-07-11 |
US6902906B1 (en) | 2005-06-07 |
CA2323576C (en) | 2010-12-07 |
NO20004781L (no) | 2000-11-08 |
CZ301520B6 (cs) | 2010-03-31 |
NO20004781D0 (no) | 2000-09-25 |
DE69925585D1 (de) | 2005-07-07 |
PL343246A1 (en) | 2001-07-30 |
NZ507077A (en) | 2002-10-25 |
WO1999049026A1 (en) | 1999-09-30 |
KR100628657B1 (ko) | 2006-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1112091A4 (en) | FAST DEEP TEMPERATURE PRESSURE STERILIZATION AND VACCINE PRODUCTION | |
HUS1300050I1 (hu) | Adjuvánsrendszerek és vakcinák | |
GB9711964D0 (en) | Live attenuated vaccines | |
IL128869A0 (en) | Pyrozolopyrimidines and pyrazolotriazines | |
IL136455A0 (en) | Attenuated invasive bacteria | |
HUP0105430A3 (en) | Attenuated bacteria and vaccines containing thereof | |
EP1142988A4 (en) | NEW MICROORGANISM AND USE THEREOF | |
HUP0103845A3 (en) | Disinfecting composition and its use | |
ZA973934B (en) | Cleaning and/or disinfecting composition | |
GB9806666D0 (en) | Antigen preparation and use | |
HUP0105392A3 (en) | Enhanced vaccines | |
HUP0204243A3 (en) | Novel helicobacter pylori-binding substances and use thereof | |
HUP0103473A3 (en) | Phosphoglycolipid and methods for its use | |
GB9822714D0 (en) | Vaccines | |
EP1123711A4 (en) | VACCINE PREPARATIONS CONTAINING AN ABRASIVE TOXIN | |
GB9802715D0 (en) | Sterilization device | |
GB9804809D0 (en) | Attenuated salmonella:materials and methods relating thereto | |
GB2344523B (en) | Portable baby bottle warmer and sterilizer | |
GB2344590B (en) | Attenuated poliovirus vaccine | |
GB2325463B (en) | Attenuated polioviruses | |
GB2316684B (en) | Degradatrive bacteria | |
GB9901850D0 (en) | Killing microorganisms | |
TW309748U (en) | Hand warmer with ultraviolet ray disinfection | |
GB9616593D0 (en) | Attenuated vaccines | |
AU6187799A (en) | Cleaning and/or treatment device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of definitive patent protection due to non-payment of fees |